Published in:
01-10-2013 | Knee
Different pattern in gap balancing between the cruciate-retaining and posterior-stabilized total knee arthroplasty
Authors:
Tomoyuki Matsumoto, Seiji Kubo, Hirotsugu Muratsu, Takehiko Matsushita, Kazunari Ishida, Yohei Kawakami, Shinya Oka, Tokio Matsuzaki, Yuichi Kuroda, Kotaro Nishida, Toshihiro Akisue, Ryosuke Kuroda, Masahiro Kurosaka
Published in:
Knee Surgery, Sports Traumatology, Arthroscopy
|
Issue 10/2013
Login to get access
Abstract
Purpose
In order to permit soft tissue balance under more physiological conditions during total knee arthroplasties (TKAs), an offset-type tensor was developed to obtain soft tissue balancing throughout the range of motion with reduced patello-femoral (PF) and aligned tibiofemoral joints. The main purpose of the present study was to assess intra-operative soft tissue balance using a navigation system with the offset-type tensor in both cruciate-retaining (CR) and posterior-stabilized (PS) TKAs.
Methods
One hundred and twenty TKAs—80 CR and 40 PS—were performed in patients with varus-type osteoarthritis using a computed tomography–free navigation system. The offset-type TKA tensor with a reduced and repaired PF joint and femoral component in place was used with the tibia first gap technique to balance soft tissues (joint component gap and ligament balance) at 0°, 10°, 30°, 60°, 90°, and 120° of flexion. The achievement in equalized rectangular gap at extension and flexion—joint component gap within ±3 mm between extension and flexion and ligament balance within ±3° at extension and flexion—was assessed retrospectively.
Results
Both types of implants showed similar patterns of soft tissue balance throughout the range of motion, whereas PS TKA had larger values especially at 60° or 90° of flexion than did CR TKA. In the achievement of equalized rectangular gaps at extension and flexion, CR TKA was superior to PS TKA.
Conclusion
Using the tibia first gap technique with the tensor allows appropriate soft tissue balancing, especially in CR TKA.
Level of evidence
Therapeutic studies, Level II.